Skip to main content

Pharmacologic treatment of bronchiolitis in infants and children: a systematic review.

Publication ,  Journal Article
King, VJ; Viswanathan, M; Bordley, WC; Jackman, AM; Sutton, SF; Lohr, KN; Carey, TS
Published in: Arch Pediatr Adolesc Med
February 2004

BACKGROUND: Bronchiolitis is the most common lower respiratory tract infection in infants. Up to 3% of all children in their first year of life are hospitalized with bronchiolitis. Bronchodilators and corticosteroids are commonly used treatments, but little consensus exists about optimal management strategies. OBJECTIVE: To conduct a systematic review of the effectiveness of commonly used treatments for bronchiolitis in infants and children. DATA SOURCES: We searched MEDLINE and the Cochrane Controlled Trials Register for references to randomized controlled trials of bronchiolitis treatment published since 1980. STUDY SELECTION: Randomized controlled trials of interventions for bronchiolitis in infants and children were included if they were published in English between 1980 and November 2002 and had a minimum sample size of 10. DATA EXTRACTION: We abstracted data on characteristics of the study population, interventions used, and results of studies meeting entry criteria into evidence tables and analyzed them by drug category. DATA SYNTHESIS: Interventions were grouped by drug category and qualitatively synthesized. RESULTS: Of 797 abstracts identified in the literature search, we included 54 randomized controlled trials. This review includes 44 studies of the most common interventions: epinephrine (n = 8), beta2-agonist bronchodilators (n = 13), corticosteroids (n = 13), and ribavirin (n = 10). Studies were, in general, underpowered to detect statistically significant outcome differences between study groups. Few studies collected data on outcomes that are of great importance to parents and clinicians, such as the need for and duration of hospitalization. CONCLUSIONS: Overall, little evidence supports a routine role for any of these drugs in treating patients with bronchiolitis. A sufficiently large, well-designed pragmatic trial of the commonly used interventions for bronchiolitis is needed to determine the most effective treatment strategies for managing this condition.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Arch Pediatr Adolesc Med

DOI

ISSN

1072-4710

Publication Date

February 2004

Volume

158

Issue

2

Start / End Page

127 / 137

Location

United States

Related Subject Headings

  • Ribavirin
  • Randomized Controlled Trials as Topic
  • Pediatrics
  • Infant, Newborn
  • Infant
  • Humans
  • Epinephrine
  • Child, Preschool
  • Child
  • Bronchodilator Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
King, V. J., Viswanathan, M., Bordley, W. C., Jackman, A. M., Sutton, S. F., Lohr, K. N., & Carey, T. S. (2004). Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med, 158(2), 127–137. https://doi.org/10.1001/archpedi.158.2.127
King, Valerie J., Meera Viswanathan, W Clayton Bordley, Anne M. Jackman, Sonya F. Sutton, Kathleen N. Lohr, and Timothy S. Carey. “Pharmacologic treatment of bronchiolitis in infants and children: a systematic review.Arch Pediatr Adolesc Med 158, no. 2 (February 2004): 127–37. https://doi.org/10.1001/archpedi.158.2.127.
King VJ, Viswanathan M, Bordley WC, Jackman AM, Sutton SF, Lohr KN, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med. 2004 Feb;158(2):127–37.
King, Valerie J., et al. “Pharmacologic treatment of bronchiolitis in infants and children: a systematic review.Arch Pediatr Adolesc Med, vol. 158, no. 2, Feb. 2004, pp. 127–37. Pubmed, doi:10.1001/archpedi.158.2.127.
King VJ, Viswanathan M, Bordley WC, Jackman AM, Sutton SF, Lohr KN, Carey TS. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med. 2004 Feb;158(2):127–137.

Published In

Arch Pediatr Adolesc Med

DOI

ISSN

1072-4710

Publication Date

February 2004

Volume

158

Issue

2

Start / End Page

127 / 137

Location

United States

Related Subject Headings

  • Ribavirin
  • Randomized Controlled Trials as Topic
  • Pediatrics
  • Infant, Newborn
  • Infant
  • Humans
  • Epinephrine
  • Child, Preschool
  • Child
  • Bronchodilator Agents